Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Even during a down period for the markets, eHealth has gone against the grain, climbing to $6.02. Its shares have yielded a 20.4% return over the last six months, beating the S&P 500 by 25.5%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
While the broader market has struggled with the S&P 500 down 5.3% since October 2024, Fastenal has surged ahead as its stock price has climbed by 6% to $81.29 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Although the S&P 500 is down 5.4% over the past six months, G-III’s stock price has fallen further to $25.58, losing shareholders 18.3% of their capital. This may have investors wondering how to approach the situation.
Shareholders of Ameresco would probably like to forget the past six months even happened. The stock dropped 66.9% and now trades at $10.51. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
